Aigen Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Aigen Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37,674	Closed	-$475K	–	514
2025 Q4	$475K	Buy	37,674 +27,443	+268%	+$314K	0.11%	254
2025 Q3	$102K	Buy	+10,231	New	+$91.8K	0.02%	737
2025 Q2	–	Sell	-15,066	Closed	-$126K	–	773
2025 Q1	$126K	Buy	+15,066	New	+$126K	0.02%	673
2024 Q4	–	Sell	-25,591	Closed	-$213K	–	717
2024 Q3	$213K	Buy	+25,591	New	+$200K	0.04%	569
2023 Q4	–	Sell	-27,905	Closed	-$118K	–	777
2023 Q3	$118K	Buy	+27,905	New	+$104K	0.02%	734
2021 Q2	–	Sell	-33,210	Closed	-$224K	–	452
2021 Q1	$224K	Buy	+33,210	New	+$184K	0.03%	506

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Aigen Investment Management's AMRX Position: Q1 2026 in Review

Aigen Investment Management sold out of Amneal Pharmaceuticals (AMRX) in Q1 2026, closing a stake of 37,674 shares — an estimated $475K sold.

Aigen Investment Management first reported a position in AMRX in Q1 2021 and held it in 6 quarters. The position peaked at $475K in Q4 2025. 317 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

Aigen Investment Management reported no remaining Amneal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Aigen Investment Management sold 37,674 Amneal Pharmaceuticals shares in Q1 2026, an estimated $475K.
Aigen Investment Management first reported a position in Amneal Pharmaceuticals in Q1 2021 and held it in 6 quarters.
Aigen Investment Management's Amneal Pharmaceuticals position peaked at $475K in Q4 2025.
317 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.